Anavex Life Sciences Corp.
AVXL | NASDAQ
$2.40
-$0.02 (-0.83%)
At close: Sep 21, 2026, 4:00 PM ET
$2.43
+$0.03 (+1.25%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -16.48 | -10.92 | -10.92 | -16.65 | -33.24 | -10.11 |
PEG Ratio | -4.29 | 0.82 | 3.38 | -1.12 | -1.66 | 0.61 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 8 | 3.94 | 3.68 | 5.57 | 8.31 | 9.72 |
P/FCF Ratio | -19.44 | -15.39 | -18.81 | -32.75 | -41.24 | -12.44 |
P/OCF Ratio | -19.44 | -15.39 | -18.81 | -32.75 | -41.24 | -12.44 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 11.60 | 8.86 | 12.32 | 14.95 | 14.97 | 4.73 |
Current Ratio | 11.60 | 8.86 | 12.32 | 14.95 | 14.97 | 4.73 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -57.85 | n/a | n/a | n/a |
Return on Equity | -48.89% | -35.76% | -33.49% | -33.67% | -25.14% | -96.49% |
Return on Assets | -44.67% | -31.72% | -30.77% | -31.42% | -23.46% | -76.08% |
Return on Invested Capital | -54.19% | -43.97% | -38.40% | -1.38% | -27.85% | -81.99% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AVXL